These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 10451755

  • 1. Parkinson's disease--levodopa complications.
    King DB.
    Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S13-20. PubMed ID: 10451755
    [Abstract] [Full Text] [Related]

  • 2. Off spells and dyskinesias: pharmacologic management of motor complications.
    Khan TS.
    Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S8-13. PubMed ID: 22761271
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Other pharmacological treatments for motor complications and dyskinesias.
    Waters C.
    Mov Disord; 2005 Jul; 20 Suppl 11():S38-44. PubMed ID: 15822104
    [Abstract] [Full Text] [Related]

  • 5. Current pharmacotherapeutic treatment options in Parkinson's disease.
    Rezak M.
    Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
    Stowe R, Ives N, Clarke CE, Deane K, van Hilten, Wheatley K, Gray R, Handley K, Furmston A.
    Cochrane Database Syst Rev; 2010 Jul 07; (7):CD007166. PubMed ID: 20614454
    [Abstract] [Full Text] [Related]

  • 15. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
    Rascol O.
    Eur J Neurol; 2011 Mar 07; 18 Suppl 1():3-10. PubMed ID: 21255197
    [Abstract] [Full Text] [Related]

  • 16. Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
    Jann MW.
    Am J Manag Care; 2011 Oct 07; 17 Suppl 12():S315-21. PubMed ID: 22087552
    [Abstract] [Full Text] [Related]

  • 17. Comparison chart: Drugs for Parkinson's disease.
    Med Lett Drugs Ther; 2020 Dec 14; 62(1613):e1-e9. PubMed ID: 33647002
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological treatment of Parkinson's disease.
    Münchau A, Bhatia KP.
    Postgrad Med J; 2000 Oct 14; 76(900):602-10. PubMed ID: 11009573
    [No Abstract] [Full Text] [Related]

  • 19. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
    Danisi F.
    Geriatrics; 2002 Mar 14; 57(3):46-50; quiz 52. PubMed ID: 11899548
    [Abstract] [Full Text] [Related]

  • 20. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Chen JJ, Fernandez HH.
    Drugs Aging; 2007 Mar 14; 24(8):663-80. PubMed ID: 17702535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.